Association of interleukin 1 family with systemic sclerosis

Inflammation

Volumn 37, Issue 4, 2014, Pages 1213-1220

  Zhang, Li ^a   Yan, Jun Wei ^b   Wang, Yu Jie ^b   Wan, Ya Nan ^b   Wang, Bing Xiang ^b   Tao, Jin Hui ^b   Chen, Bing ^b   Li, Bao Zhu ^b   Yang, Guo Jun ^b   Wang, Jing ^b  

^a Anhui Medical College   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

fibrosis; interleukin 1 family; SSc; systemic sclerosis

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 33; IL33 PROTEIN, HUMAN; INTERLEUKIN 18 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FIBROGENESIS; GENE; GENETIC ASSOCIATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; FIBROSIS; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; METABOLISM; MULTIGENE FAMILY; PHYSIOLOGY; SKIN;

FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-18; INTERLEUKINS; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN;

EID: 84904738901     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9848-7     Document Type: Article

References (55)

1. Wollheim, F.A. 2005. Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 44: 1212-1216. (Pubitemid 41487952)
2. van den Hoogen, F., D. Khanna, J. Fransen, et al. 2013. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/european league against rheumatism collaborative initiative. Arthritis and Rheumatism 65: 2737-2747.
3. Nikpour, M., W.M. Stevens, A.L. Herrick, et al. 2010. Epidemiology of systemic sclerosis. Best Practice & Research. Clinical Rheumatology 24: 857-869.
4. van de Veerdonk, F.L., and M.G. Netea. 2013. New insights in the immunobiology of IL-1 family members. Frontiers in Immunology 4: 167.
5. Dinarello, C.A. 2013. Overview of the interleukin-1 family of ligands and receptors. Semin Immunol 25: 389-393.
6. van de Veerdonk, F.L., A.K. Stoeckman, G. Wu, et al. 2012. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proceedings of the National Academy of Sciences of the United States of America 109: 3001-3005.
7. Boraschi, D., and A. Tagliabue. 2013. The interleukin-1 receptor family. Semin Immunol (13)00115-2.
8. Alcocer-Varela, J., E. Martinez-Cordero, and D. Alarcon-Segovia. 1985. Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma. Clinical and Experimental Immunology 59: 666-672. (Pubitemid 15127618)
9. Whicher, J.T., A.M. Gilbert, C. Westacott, et al. 1986. Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease. Clinical and Experimental Immunology 65: 80-89. (Pubitemid 16062993)
10. Sandborg, C.I., M.A. Berman, B.S. Andrews, et al. 1985. Interleukin-1 production by mononuclear cells from patients with scleroderma. Clinical and Experimental Immunology 60: 294-302. (Pubitemid 15099876)
11. Berman, M.A., C.I. Sandborg, B.S. Calabia, et al. 1986. Studies of an interleukin 1 inhibitor: characterization and clinical significance. Clinical and Experimental Immunology 64: 136-145. (Pubitemid 16103081)
12. Sandborg, C.I., M.A. Berman, B.S. Andrews, et al. 1986. Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma. Clinical and Experimental Immunology 66: 312-319. (Pubitemid 17175643)
13. Umehara, H., S. Kumagai, M. Murakami, et al. 1990. Enhanced production of interleukin-1 and tumor necrosis factor alpha by cultured peripheral blood monocytes from patients with scleroderma. Arthritis and Rheumatism 33: 893-897. (Pubitemid 20205772)
14. Aotsuka, S., K. Nakamura, T. Nakano, et al. 1991. Production of intracellular and extracellular interleukin-1 alpha and interleukin-1 beta by peripheral blood monocytes from patients with connective tissue diseases. Annals of the Rheumatic Diseases 50: 27-31.
15. Kawaguchi, Y., M. Harigai, M. Hara, et al. 1992. Increased interleukin 1 receptor, type I, at messenger RNA and protein level in skin fibroblasts from patients with systemic sclerosis. Biochemical and Biophysical Research Communications 184: 1504-1510.
16. Kawaguchi, Y., M. Harigai, K. Suzuki, et al. 1993. Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta. Biochemical and Biophysical Research Communications 190: 154-161. (Pubitemid 23227301)
17. Kawaguchi, Y. 1994. IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clinical and Experimental Immunology 97: 445-450.
18. Duan, H., J. Fleming, D.K. Pritchard, et al. 2008. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis and Rheumatism 58: 1465-1474. (Pubitemid 351705936)
19. Maekawa, T., M. Jinnin, M. Ohtsuki, et al. 2013. Serum levels of interleukin-1alpha in patients with systemic sclerosis. Journal of Dermatology 40: 98-101.
20. Andersen, G.N., K. Nilsson, O. Nagaeva, et al. 2011. Cytokine mRNA profile of alveolar T lymphocytes and macrophages in patients with systemic sclerosis suggests a local Tr1 response. Scandinavian Journal of Immunology 74: 272-281.
21. Higgins, G.C., Y. Wu, and A.E. Postlethwaite. 1999. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha. Journal of Immunology 163: 3969-3975. (Pubitemid 29450926)
22. Kawaguchi, Y., M. Hara, and T.M. Wright. 1999. Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A. Journal of Clinical Investigation 103: 1253-1260. (Pubitemid 29218295)
23. Kawaguchi, Y., S.A. McCarthy, S.C. Watkins, et al. 2004. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts. Journal of Rheumatology 31: 1946-1954. (Pubitemid 39336718)
24. Kirk, T.Z., and M.D. Mayes. 1999. IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death. Biochemical and Biophysical Research Communications 255: 129-132. (Pubitemid 29292076)
25. Hu, B., S. Wang, Y. Zhang, et al. 2003. A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression. Proceedings of the National Academy of Sciences of the United States of America 100: 10008-10013. (Pubitemid 37087059)
26. Kawaguchi, Y., E. Nishimagi, A. Tochimoto, et al. 2006. Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 103: 14501-14506. (Pubitemid 44484779)
27. Zamostna, B., J. Novak, V. Vopalensky, et al. 2012. N-terminal domain of nuclear IL-1alpha shows structural similarity to the C-terminal domain of Snf1 and binds to the HAT/core module of the SAGA complex. PLoS One 7: e41801.
28. Aden, N., A. Nuttall, X. Shiwen, et al. 2010. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. Journal of Investigative Dermatology 130: 2191-2200.
29. Yamamoto, T., Y. Sawada, I. Katayama, et al. 1998. Increased production of nitric oxide stimulated by interleukin-1beta in peripheral blood mononuclear cells in patients with systemic sclerosis. British Journal of Rheumatology 37: 1123-1125.
30. Kanangat, S., A.E. Postlethwaite, G.C. Higgins, and K.A. Hasty. 2006. Novel functions of intracellular IL-1ra in human dermal fibroblasts: implications in the pathogenesis of fibrosis. Journal of Investigative Dermatology 126: 756-765.
31. Kawaguchi, Y., A. Tochimoto, N. Ichikawa, et al. 2003. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis and Rheumatism 48: 186-192. (Pubitemid 36091662)
32. Kawaguchi, Y., M. Hara, N. Kamatani, et al. 2003. Identification of an IL1A gene segment that determines aberrant constitutive expression of interleukin-1 alpha in systemic sclerosis. Arthritis and Rheumatism 48: 193-202. (Pubitemid 36091663)
33. Kawaguchi, Y., A. Tochimoto, M. Hara, et al. 2007. Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1alpha and its transcription activity. Immunogenetics 59: 441-448. (Pubitemid 46684721)
34. Hutyrova, B., J. Lukac, V. Bosak, et al. 2004. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis. Journal of Rheumatology 31: 81-84. (Pubitemid 38067526)
35. Beretta, L., F. Bertolotti, F. Cappiello, et al. 2007. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. Human Immunology 68: 603-609. (Pubitemid 46920553)
36. Beretta, L., F. Cappiello, J.H. Moore, et al. 2008. Interleukin-1 gene complex single nucleotide polymorphisms in systemic sclerosis: a further step ahead. Human Immunology 69: 187-192.
37. Beretta, L., F. Cappiello, J.H. Moore, et al. 2008. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Arthritis and Rheumatism 59: 974-983. (Pubitemid 351990994)
38. Mattuzzi, S., S. Barbi, A. Carletto, et al. 2007. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. Journal of Rheumatology 34: 997-1004. (Pubitemid 46774845)
39. Wang, S., L. Ding, S.S. Liu, et al. 2012. IL-33: a potential therapeutic target in autoimmune diseases. Journal of Investigative Medicine 60: 1151-1156.
40. Manetti, M., L. Ibba-Manneschi, V. Liakouli, et al. 2010. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Annals of the Rheumatic Diseases 69: 598-605.
41. Manetti, M., S. Guiducci, C. Ceccarelli, et al. 2011. Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement. Annals of the Rheumatic Diseases 70: 1876-1878.
42. Yanaba, K., A. Yoshizaki, Y. Asano, et al. 2011. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clinical Rheumatology 30: 825-830.
43. Terras, S., E. Opitz, R.K. Moritz, et al. 2013. Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis. Annals of the Rheumatic Diseases 72: 144-145.
44. Wen, D., J. Liu, X. Du, et al. 2013. Association of interleukin-18 (-137G/C) polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. International Reviews of Immunology. doi:10.3109/08830185.2013.816699.
45. Pan, H.F., J. Wang, R.X. Leng, et al. 2011. Interleukin-18: friend or foe for systemic sclerosis. Journal of Investigative Dermatology 131: 2495.
46. Tochimoto, A., E. Nishimagi, Y. Kawaguchi, et al. 2001. A case of recurrent hemophagocytic syndrome complicated with systemic sclerosis: relationship between disease activity and serum level of IL-18. Ryūmachi 41: 659-664. (Pubitemid 32679175)
47. Mosaad, Y.M., S.S. Metwally, F.A. Auf, et al. 2003. Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: relation with disease activity and autoantibodies production. The Egyptian Journal of Immunology 10: 19-26.
48. Scala, E., S. Pallotta, A. Frezzolini, et al. 2004. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clinical and Experimental Immunology 138: 540-546. (Pubitemid 39573637)
49. Kim, H.J., S.B. Song, J.M. Choi, et al. 2010. IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway. Journal of Investigative Dermatology 130: 706-715.
50. Artlett, C.M., S. Sassi-Gaha, J.L. Rieger, et al. 2011. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis and Rheumatism 63: 3563-3574.
51. Artlett, C.M. 2012. The role of the NLRP3 inflammasome in fibrosis. Open Rheumatology Journal 6: 80-86.
52. Gresnigt, MS, and F.L. van de Veerdonk. 2013. Biology of IL-36 cytokines and their role in disease. Semin Immunol (13)00155-3.
53. Rahman, P., S. Sun, L. Peddle, et al. 2006. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis and Rheumatism 54: 2321-2325. (Pubitemid 44051093)
54. Boraschi, D., D. Lucchesi, S. Hainzl, et al. 2011. IL-37: a new antiinflammatory cytokine of the IL-1 family. European Cytokine Network 22: 127-147.
55. Song, L., F. Qiu, Y. Fan, et al. 2013. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. Journal of Clinical Immunology 33: 111-117.